close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xenetic Biosciences, Inc. - Common Stock (NQ:XBIO)

2.440 -0.130 (-5.06%)
Streaming Delayed Price Updated: 11:27 AM EDT, Sep 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,727
Open 2.650
Bid (Size) 2.430 (100)
Ask (Size) 2.540 (100)
Prev. Close 2.570
Today's Range 2.440 - 2.650
52wk Range 1.870 - 13.93
Shares Outstanding 2,291,056
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Transaction expected to create a Nasdaq-listed, multi-indication clinical-stage company focused on targeting neutrophil extracellular traps (NETs), a driver of disease across critical care, autoimmune... 
From Xenetic Biosciences, Inc.
Via ACCESS Newswire
News headline image
Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform
From Xenetic Biosciences, Inc.
Via ACCESS Newswire

Performance

YTD
+13.5%
+13.5%
1 Month
-36.0%
-36.0%
3 Month
-15.9%
-15.9%
6 Month
-18.4%
-18.4%
1 Year
-21.8%
-21.8%

More News

Read More
News headline image
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
Via ACCESS Newswire
News headline image
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
Via ACCESS Newswire
News headline image
Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Via ACCESS Newswire
News headline image
Why Did UPB Stock Pop 20% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
Via ACCESS Newswire
News headline image
Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges ↗
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
News headline image
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
Via ACCESS Newswire
News headline image
4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings ↗
Via Benzinga
News headline image
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
News headline image
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Nasdaq Gains 150 Points; US Mortgage Applications Decline ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga

Frequently Asked Questions

Is Xenetic Biosciences, Inc. - Common Stock publicly traded?
Yes, Xenetic Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Xenetic Biosciences, Inc. - Common Stock trade on?
Xenetic Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xenetic Biosciences, Inc. - Common Stock?
The ticker symbol for Xenetic Biosciences, Inc. - Common Stock is XBIO on the Nasdaq Stock Market
What is the current price of Xenetic Biosciences, Inc. - Common Stock?
The current price of Xenetic Biosciences, Inc. - Common Stock is 2.440
When was Xenetic Biosciences, Inc. - Common Stock last traded?
The last trade of Xenetic Biosciences, Inc. - Common Stock was at 09/23/26 11:27 AM ET
What is the market capitalization of Xenetic Biosciences, Inc. - Common Stock?
The market capitalization of Xenetic Biosciences, Inc. - Common Stock is 5.59M
How many shares of Xenetic Biosciences, Inc. - Common Stock are outstanding?
Xenetic Biosciences, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.